50 ACTIVITY OF TELAPREVIR ALONE OR IN COMBINATION WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN IN TREATMENT-NAIVE GENOTYPE 2 AND 3 HEPATITIS-C PATIENTS: INTERIM RESULTS OF STUDY C209
Graham R. FosterChristophe HézodeInstitute of Nuclear Medicine,J.‐P. BronowickiG. CarosiCharité -Campus Virchow Klinikum, Berlin, Germany;Ola WeilandOspedale Maggiore Policlinico, Mangiagalli e Regina Elena, Milano, Italy;Lieselotte VerlindenInstitute of Nuclear Medicine,Rolf van HeeswijkHeritage Medical Research ClinicTony VangeneugdenCharité -Campus Virchow Klinikum, Berlin, Germany;Gastón PicchioCharité -Campus Virchow Klinikum, Berlin, Germany;Maria Beumont‐MauvielHospital Universitario Gaffree & Guinle, Rio de Janeiro, Brazil;
Ochiq kirish: yoʻq
ABI
Annotatsiya
Annotatsiya mavjud emas.
Mavzular
Identifikatorlar
Iqtiboslar va manbalar
0 ta iqtibos0 ta foydalanilgan manba